论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
2011 年至 2015 年中国腹腔感染者大肠杆菌和分离自腹腔感染者的 肺炎克雷伯菌病原菌的抗菌药物敏感性变化
Authors Zhang H, Tong D, Johnson A, Zhang G, Xu Z, Yang Y, Zhang J, Li D, Duan S, Wang Y, Yang Q, Xu Y
Received 11 April 2019
Accepted for publication 25 July 2019
Published 9 August 2019 Volume 2019:12 Pages 2477—2486
DOI https://doi.org/10.2147/IDR.S211952
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Joachim Wink
Background: To explore the susceptibility trends of antimicrobials and resistance increase to antibiotics of Enterobacteriaceae isolated from patients in China with intra-abdominal infections (IAI) from 2011 to 2015.
Methods: MIC90 and MIC50 values of 12 commonly used antibiotics from Escherichia coli and Klebsiella pneumoniae isolated from IAI samples were determined.
Results: A total of 8,477 Gram-negative bacterial pathogens were collected from 21 medical centers in China. The majority of IAI isolate-derived pathogens were E. coli (3,854, 45.5%) and K. pneumoniae (1,670, 19.7%) of which 1,990 (23.5%) were consecutively collected from community acquired (CA) and 6,186 (73.0%) from hospital acquired (HA) IAIs. The drugs with the highest efficacy against E. coli and K. pneumoniae isolates derived from IAI samples were imipenem, ertapenem, amikacin and piperacillin-tazobactam. MIC90 values for piperacillin-tazobactam were 64 μg/mL in 2015 with fluctuations from 16–64 μg/mL through the years for E. coli , but were stable at ≥64 μg/mL from 2011 to 2015 for K. pneumoniae isolates. Susceptibilities to ertapenem, imipenem and amikacin were high for E. coli isolates throughout the study, but K. pneumoniae isolated from abscesses, colon and peritoneal fluid collected from medical and surgical ICUs showed an increasing trend of carbapenem resistance in 2015.
Conclusion: In 2015 there was a trend of enhanced carbapenem resistance, particularly for K. pneumoniae isolated from IAI samples obtained from patients in ICUs.
Keywords: MIC, Enterobacteriaceae , intra-abdominal infection, carbapenems, cefepime, piperacillin-tazobactam